Molecular mechanisms of action and chemosensitization of tumor cells in ovarian cancer by phytochemicals: A narrative review on pre‐clinical and clinical studies
JR Barboza, FAN Pereira… - Phytotherapy …, 2023 - Wiley Online Library
Ovarian cancer is the second‐leading cause of death among women with cancer of the
genital tract. Currently, drugs derived from platinum and taxanes constitute the majority of …
genital tract. Currently, drugs derived from platinum and taxanes constitute the majority of …
Advances of plant-derived natural products in ovarian cancer therapy
WW Li, O Rosa Johnson-Ajinwo… - … Journal of Cancer …, 2016 - keele-repository.worktribe.com
Ovarian cancer is the leading cause of death in the gynaecologic cancers within the UK and
US. Presently the standard treatment for ovarian cancer entails the use of chemotherapy …
US. Presently the standard treatment for ovarian cancer entails the use of chemotherapy …
Current Prospects of Phytochemical-Based Treatment for Ovarian Cancer: A Brief Review
S Jhulki, A Pal - Indian Journal of Gynecologic Oncology, 2023 - Springer
Purpose Ovarian cancer is a complex lethal gynecological malignancy, and its nonspecific
symptoms create major challenges to diagnose it in primary stages. Late stage diagnosis of …
symptoms create major challenges to diagnose it in primary stages. Late stage diagnosis of …
Mechanisms and advances in anti-ovarian cancer with natural plants component
J Wu, T Zhou, Y Wang, Y Jiang, Y Wang - Molecules, 2021 - mdpi.com
Ovarian cancer ranks seventh in the most common malignant tumors among female
disease, which seriously threatens female reproductive health. It is characterized by hidden …
disease, which seriously threatens female reproductive health. It is characterized by hidden …
The use of natural compounds for the targeting and chemoprevention of ovarian cancer
Among gynaecological cancers, ovarian cancer represents the leading cause of death in
women. Current treatment for ovarian cancer entails surgery followed by combined …
women. Current treatment for ovarian cancer entails surgery followed by combined …
The role of natural and semi-synthetic compounds in ovarian cancer: Updates on mechanisms of action, current trends and perspectives
MR Islam, MM Rahman, PS Dhar, FT Nowrin… - Molecules, 2023 - mdpi.com
Ovarian cancer represents a major health concern for the female population: there is no
obvious cause, it is frequently misdiagnosed, and it is characterized by a poor prognosis …
obvious cause, it is frequently misdiagnosed, and it is characterized by a poor prognosis …
Antitumor effects and molecular mechanisms of action of natural products in ovarian cancer
YB Yan, Q Tian, JF Zhang, Y Xiang - Oncology letters, 2020 - spandidos-publications.com
Ovarian cancer is a common malignancy and the second leading cause of mortality among
females with genital tract cancer. At present, postoperative platinum drugs and paclitaxel …
females with genital tract cancer. At present, postoperative platinum drugs and paclitaxel …
[PDF][PDF] Phytochemicals in the treatment of ovarian cancer
J Rais, A Jafri, S Siddiqui, M Tripathi… - Front Biosci (Elite …, 2017 - article.imrpress.com
Ovarian cancer ranks 5th among the most common gynecologic cancers and causes the
highest mortality in females. Here, we discuss the role of a group of natural products that are …
highest mortality in females. Here, we discuss the role of a group of natural products that are …
Phenolic acids-mediated regulation of molecular targets in Ovarian Cancer: current understanding and future perspectives
Cancer is a global health concern with a dynamic rise in occurrence and one of the leading
causes of mortality worldwide. Among different types of cancer, ovarian cancer (OC) is the …
causes of mortality worldwide. Among different types of cancer, ovarian cancer (OC) is the …
[HTML][HTML] Advances in the treatment of ovarian Cancer—A potential role of anti-inflammatory phytochemicals
SS Chen, A Michael… - Discovery …, 2012 - discoverymedicine.com
Epithelial ovarian cancer (EOC) is the leading cause of death among gynecological
malignancies worldwide. The five-year survival rates for stage IIIC and IV patients are 29 …
malignancies worldwide. The five-year survival rates for stage IIIC and IV patients are 29 …